You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ap1903

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

Completed
  • Sarcoma
  • +3 more
  • Anti-GD2-CAR engineered T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

Recruiting
  • Lymphoma
  • +4 more
  • iC9-CAR19 T cells
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

No longer available
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021

Breast Cancer, Metastatic HER2-negative Breast Trial in United States (Cyclophosphamide, Mesothelin-targeted T cells, AP1903)

Active, not recruiting
  • Breast Cancer
  • Metastatic HER2-negative Breast
  • Basking Ridge, New Jersey
  • +6 more
Mar 21, 2022

Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

Withdrawn
  • Hematologic Malignancies
  • BPX-501
  • AP1903
  • Houston, Texas
    MD Anderson Cancer Center
Oct 1, 2020

Castrate Resistant Prostate Cancer (CRPC) Trial in Houston (BPX-101, AP1903)

Completed
  • Castrate Resistant Prostate Cancer (CRPC)
  • BPX-101
  • AP1903
  • Houston, Texas
    University of Texas Health Science Center Houston, CRU
Oct 4, 2019

Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

Terminated
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 24, 2019